Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

Clinical trial NCT00061035 · COMPLETED

Trial details

NCT number: NCT00061035
Sponsor: Cosmo Bioscience
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2003-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.